Skip to main content
. 2019 Feb 11;11(2):208. doi: 10.3390/cancers11020208

Figure 7.

Figure 7

Expression of ORAI3 in combination with ORAI1 stratifies the survival of Basal, ER- and TNBC. Stratification of patient relapse free survival (RFS) in basal, estrogen-receptor negative (ER-) and triple negative breast cancer (TNBC) from the KM Plotter cohorts. Stratification of patient survival was based on ORAI3 expression in (A–C), and on ORAI3 in combination with ORAI1 expression in (D–F), where ‘high’ group (red) is high expression of ORAI3 and low expression of ORAI1 and the ‘low’ group (black) is low expression of ORAI3 and high expression of ORAI1.